+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

All Genders
ID06711562

Personalized Treatment of Bone and Joint Infections Using Anti-Infective Drugs Based on Drug Levels in Blood and Tissues

Led by Shandong University · Updated on 2024-12-02

300

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What this Trial Is About

Researchers are evaluating how to optimize personalized treatment of anti-infective drugs for people with osteoarticular infections by studying drug levels in the blood and tissues. This observational study aims to better understand how these drugs behave in the body using population pharmacokinetics, which can help guide dosing decisions. Participants will receive anti-infective drugs following traditional clinical dosing without additional interventions. The study mainly observes and collects data on drug clearance and distribution over about 30 days. During the study, participants will have their drug exposure measured through blood or tissue samples. Researchers will also monitor markers like erythrocyte sedimentation rate and record any adverse events. The study lasts approximately 30 days to collect all relevant data for analysis.

CONDITIONS

Brief Title

Model-informed Individualized Treatment of Anti-infective Drugs

Research Team

W

Wei Zhao, Ph.D

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here